PMDA Notice: Heparinoid Lotion 0.3% 'NIT' Nitrosamine Detection, Voluntary Recall (Class II)
「ヘパリン類似物質ローション0.3％「NIT」ニトロソアミン化合物検出及び自主回収（クラスⅡ）に関するお知らせ」を掲載しました
Published: 2026-10-13 · Source: Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Stage: Government Announcement · Area: Healthcare / Pharmaceuticals · Impact (preliminary): Medium · First detected by this dashboard: 2026-10-14
View the original Japanese source More Healthcare / Pharmaceuticals updates Search all updates in the dashboard
AI summary
Generated by AI from the Japanese source metadata. It is an unofficial monitoring aid, not legal advice, and may contain errors. The area, stage, and impact labels are preliminary keyword-based triage labels. Confirm every point in the original Japanese source.
Summary
The PMDA safety information page lists a newly posted notice (dated 2026-10-13) concerning Heparinoid (heparin-analogue) Lotion 0.3% 'NIT'. Based on the title, the notice relates to the detection of nitrosamine compounds and a voluntary recall classified as Class II. The notice content itself was not provided, so specifics such as affected lots, quantities, or recall scope are not known from this metadata.
Business Impact
Pharmaceutical manufacturers, distributors, pharmacies, and healthcare providers handling this product may need to check whether their stock is affected by the recall. Details on handling and scope would depend on the official notice.
Recommended Action
Consider reviewing the original PMDA notice at the source URL to confirm the affected product details, recall scope, and any stated handling instructions.